170 related articles for article (PubMed ID: 1400878)
1. Serum propeptide and intact molecular osteocalcin in normal children and children with growth hormone (GH) deficiency: a potential marker of bone growth and response to GH therapy.
Kanzaki S; Hosoda K; Moriwake T; Tanaka H; Kubo T; Inoue M; Higuchi J; Yamaji T; Seino Y
J Clin Endocrinol Metab; 1992 Oct; 75(4):1104-9. PubMed ID: 1400878
[TBL] [Abstract][Full Text] [Related]
2. Serum bone alkaline phosphatase isoenzyme levels in normal children and children with growth hormone (GH) deficiency: a potential marker for bone formation and response to GH therapy.
Tobiume H; Kanzaki S; Hida S; Ono T; Moriwake T; Yamauchi S; Tanaka H; Seino Y
J Clin Endocrinol Metab; 1997 Jul; 82(7):2056-61. PubMed ID: 9215272
[TBL] [Abstract][Full Text] [Related]
3. Serum bone Gla protein: a potential marker of growth hormone (GH) deficiency and the response to GH therapy.
Johansen JS; Jensen SB; Riis BJ; Rasmussen L; Zachmann M; Christiansen C
J Clin Endocrinol Metab; 1990 Jul; 71(1):122-6. PubMed ID: 2370291
[TBL] [Abstract][Full Text] [Related]
4. [Changes in osteocalcin serum levels in children with growth hormone deficiency during substitution therapy].
Muzsnai A; Péter F; Tarján G; Holló I
Orv Hetil; 1994 Feb; 135(6):291-4. PubMed ID: 8309685
[TBL] [Abstract][Full Text] [Related]
5. Urinary pyridinium collagen cross-links predict growth performance in children with idiopathic short stature and with growth hormone (GH) deficiency treated with GH. Skeletal metabolism during GH treatment.
Spagnoli A; Branca F; Spadoni GL; Cianfarani S; Pasquino AM; Argirò G; Vitale S; Robins SP; Boscherini B
J Clin Endocrinol Metab; 1996 Oct; 81(10):3589-93. PubMed ID: 8855806
[TBL] [Abstract][Full Text] [Related]
6. [Serum levels of intact molecular osteocalcin in children with growth hormone (GH) deficiency during GH therapy: an early predictor of GH therapy].
Seino Y; Kanzaki S; Kubo T; Hibi I; Tanaka T; Suwa S; Tachibana K; Okuno A; Niimi H; Tsuchiya Y
Nihon Naibunpi Gakkai Zasshi; 1994 Dec; 70(10):1063-74. PubMed ID: 7859886
[TBL] [Abstract][Full Text] [Related]
7. Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency.
Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; Di Nero G
J Pediatr; 1993 Jan; 122(1):37-45. PubMed ID: 8419613
[TBL] [Abstract][Full Text] [Related]
8. Short-term changes in bone formation markers following growth hormone (GH) treatment in short prepubertal children with a broad range of GH secretion.
Andersson B; Swolin-Eide D; Magnusson P; Albertsson-Wikland K
Clin Endocrinol (Oxf); 2015 Jan; 82(1):91-9. PubMed ID: 24818653
[TBL] [Abstract][Full Text] [Related]
9. Secretion of osteocalcin and its propeptide from human osteoblastic cells: dissociation of the secretory patterns of osteocalcin and its propeptide.
Hosoda K; Kanzaki S; Eguchi H; Kiyoki M; Yamaji T; Koshihara Y; Shiraki M; Seino Y
J Bone Miner Res; 1993 May; 8(5):553-65. PubMed ID: 8511982
[TBL] [Abstract][Full Text] [Related]
10. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children.
Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; DiNero G
Pediatr Res; 1994 Apr; 35(4 Pt 1):409-15. PubMed ID: 8047377
[TBL] [Abstract][Full Text] [Related]
11. [Serum osteocalcin and bone alkaline phosphatase in healthy children in relation to age and gender].
Ambroszkiewicz J; Gajewska J; Laskowska-Klita T
Med Wieku Rozwoj; 2002; 6(3):257-65. PubMed ID: 12637780
[TBL] [Abstract][Full Text] [Related]
12. Serum free insulin-like growth factor I (IGF-I), total IGF-I, and IGF-binding protein-3 concentrations in normal children and children with growth hormone deficiency.
Kawai N; Kanzaki S; Takano-Watou S; Tada C; Yamanaka Y; Miyata T; Oka M; Seino Y
J Clin Endocrinol Metab; 1999 Jan; 84(1):82-9. PubMed ID: 9920066
[TBL] [Abstract][Full Text] [Related]
13. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
[TBL] [Abstract][Full Text] [Related]
14. 24-h profile of serum osteocalcin in growth hormone (GH) deficient patients with and without GH treatment.
Nielsen HK; Jørgensen JO; Brixen K; Møller N; Charles P; Christensen JS
Growth Regul; 1991 Dec; 1(4):153-9. PubMed ID: 1842347
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of carboxyterminal propeptide of type I procollagen and pyridinoline crosslinked telopeptide of type I collagen in normal children and children with growth hormone (GH) deficiency during GH therapy.
Kubo T; Tanaka H; Inoue M; Kanzaki S; Seino Y
Bone; 1995 Oct; 17(4):397-401. PubMed ID: 8573414
[TBL] [Abstract][Full Text] [Related]
16. Serum bone Gla-protein as a marker of bone growth in children and adolescents: correlation with age, height, serum insulin-like growth factor I, and serum testosterone.
Johansen JS; Giwercman A; Hartwell D; Nielsen CT; Price PA; Christiansen C; Skakkebaek NE
J Clin Endocrinol Metab; 1988 Aug; 67(2):273-8. PubMed ID: 3260598
[TBL] [Abstract][Full Text] [Related]
17. Serum aminoterminal propeptide of type III procollagen: a potential predictor of the response to growth hormone therapy.
Tapanainen P; Risteli L; Knip M; Käär ML; Risteli J
J Clin Endocrinol Metab; 1988 Dec; 67(6):1244-9. PubMed ID: 3192681
[TBL] [Abstract][Full Text] [Related]
18. Renal handling of phosphate can predict height velocity during growth hormone therapy for short children.
Nishiyama S; Ikuta M; Nakamura T; Tomoeda S; Matsuda I
J Clin Endocrinol Metab; 1992 Apr; 74(4):906-9. PubMed ID: 1548358
[TBL] [Abstract][Full Text] [Related]
19. Serum bone GLA-protein in growth hormone deficient children.
Delmas PD; Chatelain P; Malaval L; Bonne G
J Bone Miner Res; 1986 Aug; 1(4):333-8. PubMed ID: 3509741
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human insulin-like growth factor I, recombinant human growth hormone, and sex steroids: effects on markers of bone turnover in humans.
Mauras N; Doi SQ; Shapiro JR
J Clin Endocrinol Metab; 1996 Jun; 81(6):2222-6. PubMed ID: 8964855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
